Organization

Field Name

ID

Required

KCR

Grade Post Therapy Path (yp)

30138

yes 

SEER

Grade Post Therapy Path (yp)

3845

yes 

Note 1 Leave Grade Post Therapy Path (yp) blank when

Note 2 There is a preferred grading system for this schema. If the post therapy clinical grade given uses the preferred grading system and the post therapy pathological grade does not use the preferred grading system, do not record the Grade Post Therapy Clin (yc) in the Grade Post Therapy Path (yp) field. Assign Grade Post Therapy Path (yp) using the applicable generic grade codes (A-D).

Note 3 Assign the highest grade from the resected primary tumor assessed after the completion of neoadjuvant therapy.

Note 4 If there are multiple tumors with different grades abstracted as one primary, code the highest grade.

Note 5 Priority order for codes

Note 6 Scarff-Bloom-Richardson (SBR) score is used for grade. SBR is also referred to as Bloom-Richardson, Nottingham, Nottingham modification of Bloom-Richardson score, Nottingham modification, Nottingham-Tenovus grade, or Nottingham score.

Note 7 All invasive breast carcinomas should be assigned a histologic grade. The Nottingham combined histologic grade (Nottingham modification of the SBR grading system) is recommended. The grade for a tumor is determined by assessing morphologic features (tubule formation, nuclear pleomorphism, and mitotic count), assigning a value from 1 (favorable) to 3 (unfavorable) for each feature, and totaling the scores for all three categories. A combined score of 3-5 points is designated as grade 1; a combined score of 6-7 points is grade 2; a combined score of 8-9 points is grade 3.

Note 8 Grade from nodal tissue may be used ONLY when there was never any evidence of primary tumor (T0). Grade would be coded using G1, G2, or G3, even if the grading is not strictly Nottingham, which is difficult to perform in nodal tissue. Some of the terminology may include differentiation terms without some of the morphologic features used in Nottingham (e.g., well differentiated (G1), moderately differentiated (G2), or poorly/undifferentiated (G3)).

Note 9 Use the grade from the post therapy clinical work up from the primary tumor in different scenarios based on behavior or surgical resection

Note 10 Code 9 (unknown) when

Note 11 If you are assigning an AJCC 8th edition stage group

Code

Description

1

G1: Low combined histologic grade (favorable), SBR score of 3-5 points
Stated as Nottingham/Scarff Bloom-Richardson Grade 1

2

G2: Intermediate combined histologic grade (moderately favorable); SBR score of 6-7 points
Stated as Nottingham/Scarff Bloom-Richardson Grade 2

3

G3: High combined histologic grade (unfavorable); SBR score of 8-9 points
Stated as Nottingham/Scarff Bloom-Richardson Grade 3

L

Nuclear Grade I (Low) (in situ only)

M

Nuclear Grade II (interMediate) (in situ only)

H

Nuclear Grade III (High) (in situ only)

A

Well differentiated

B

Moderately differentiated

C

Poorly differentiated

D

Undifferentiated, anaplastic

9

Grade cannot be assessed (GX); Unknown

<BLANK>

See Note 1